DKDaniel KuritzkesMDSlidesetHIVEuropean HIV Clinical Forum 2022Current and Evolving Therapeutic Options for Highly Treatment Experienced Patients - Daniel Kuritzkes, MDView Slideset
GRGary RubinMD, MCFP, AAHIVSSlidesetHIVEuropean HIV Clinical Forum 2022Considerations in Switching to Newer Regimens in Patients Suppressed on Older Drugs - Gary Rubin, MD, MCFP, AAHIVSView Slideset
AMGAnna Maria GerettiMD, PhD, FRCPathVideoHIVEuropean HIV Clinical Forum 2022Integrating Multiple Novel Agents for Optimal Care of Multiclass Resistant Patients - Anna Maria Geretti, MD, PhD, FRCPathView Video
JMLJosep M. LlibreMD, PhDVideoHIVEuropean HIV Clinical Forum 2022Clinical Case - Josep Llibre, MD, PhDView Video
DKDaniel KuritzkesMDVideoHIVEuropean HIV Clinical Forum 2022Current & Evolving Therapeutic Options for Highly Treatment Experienced Patients - Daniel Kuritzkes, MD, PhDView Video
EREmma RubensteinMD, MPHVideoHIVEuropean HIV Clinical Forum 2022Clinical Case - Emma Rubenstein, MD, MPHView Video
JMJean-Michel MolinaMD, PhDVideoHIVEuropean HIV Clinical Forum 2022How to Choose Between Oral and IM PrEP for Each Individual - Jean-Michel Molina, MD, PhDView Video
DJDavid JilichMD, PhDVideoHIVEuropean HIV Clinical Forum 2022Update on Therapeutic Options for HIV Prevention - David Jilich, MDView Video
MPMiłosz ParczewskiMD, PhDVideoHIVEuropean HIV Clinical Forum 2022Clinical Case - Miłosz Parczewski, MD, PhDView Video
GRGary RubinMD, MCFP, AAHIVSVideoHIVEuropean HIV Clinical Forum 2022Considerations in Switching to Newer Regimens in Patients Suppressed on Older Drugs - Gary Rubin, MD, MCFP, AAHIVSView Video
EMEsteban MartínezMD, PhDVideoHIVEuropean HIV Clinical Forum 2022Comorbidity and Toxicity Considerations in Choice of Regimen - Esteban Martinez, MD, PhDView Video
SKSaye KhooMD, PhDVideoHIVEuropean HIV Clinical Forum 2022Pharmacological Considerations in Choice of Regimen - Saye Khoo, MD, PhDView Video
